EX-99.1 2 ss74346_ex9901.htm JOINT FILING AGREEMENT

EXHIBIT 1
JOINT FILING AGREEMENT
 
The undersigned hereby agree that the Statement on this Schedule 13D, dated January 5, 2018 (the “Schedule 13D”), with respect to the Common Stock, of Pieris Pharmaceuticals, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D.  Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein.  This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
 
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 5th day of January 2018.
                
 
OrbiMed Advisors LLC
 
 
 
 
  
 
         
  By: /s/ Samuel D. Isaly  
    Name: Samuel D. Isaly  
    Title: Managing Member  
         
 
 
 
  
 
 
OrbiMed Capital GP III LLC
 
         
  By: OrbiMed Advisors LLC
its Managing Member 		 
       
         
  By: /s/ Samuel D. Isaly  
    Name: Samuel D. Isaly  
    Title: Managing Member  
         
  Samuel D. Isaly  
     
       
  /s/ Samuel D. Isaly  
  Name: Samuel D. Isaly